Tag Archives: Ceftriaxone Market Share

The efficacy of ceftriaxone in treating multidrug-resistant infections, the increasing prevalence of bacterial infections, and the investigation of novel therapeutic applications are factors that are anticipated to propel the market at a CAGR of 3.1% from 2024 to 2032. However, ongoing consideration is necessary to address challenges associated with antibiotic stewardship and resistance concerns. The segmentation analysis underscores the increasing ...